Approximately one‐half of individuals with cancer face personal economic burdens
associated with the disease and its treatment, a problem known as financial toxicity (FT). FT …

Abstract “Financial toxicity” has now become a familiar term used in the discussion of cancer
drugs, and it is gaining traction in the literature given the high price of newer classes of …

In 2017, the Seventieth World Health Assembly adopted resolution WHA70. 12 on Cancer
prevention and control in the context of an integrated approach (Appendix A). Operative …

Abstract Background The American Cancer Society (ACS), the Centers for Disease Control
and Prevention (CDC), the National Cancer Institute (NCI), and the North American …

Purpose To provide an updated joint ASCO/Infectious Diseases Society of America (IDSA)
guideline on antimicrobial prophylaxis for adult patients with immunosuppression …

During the past few decades, the incidence of thyroid cancer has increased substantially in
many countries, including the USA. The rise in incidence seems to be attributable both to the …

Background: Patients with cancer experience financial toxicity from the costs of treatment, as
well as material and psychologic stress related to this burden. A synthesized understanding …

Background: With rising cancer care costs, including high-priced cancer drugs, financial
hardship is increasingly documented among cancer survivors in the United States; research …

The treatment of advanced thyroid cancer has undergone rapid evolution in the last decade,
with multiple kinase inhibitor drug approvals for each subtype of thyroid cancer and a …

Purpose To provide an updated joint ASCO/Infectious Diseases Society of American (IDSA)
guideline on outpatient management of fever and neutropenia in patients with cancer …